Research Topics
| Aparna K MohanSummaryAffiliation: Food and Drug Administration Country: USA Publications
| Collaborators
|
Detail Information
Publications
Breast cancer mortality among female radiologic technologists in the United StatesAparna K Mohan
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7244, USA
J Natl Cancer Inst 94:943-8. 2002..The high risks of breast cancer mortality for women exposed to occupational radiation prior to 1950 and the subsequent decline in risk are consistent with the dramatic reduction in recommended radiation exposure limits over time...- Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitorAparna K Mohan
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Rockville, Maryland, USA
Clin Infect Dis 39:295-9. 2004..It is unclear whether etanercept therapy increases the risk of TB beyond the elevated TB rates already documented for patients with RA... - Deaths among children less than two years of age receiving palivizumab: an analysis of comorbiditiesAparna K Mohan
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1404 Rockville Pike, Suite 200S, Bethesda, MD 20852, USA
Pediatr Infect Dis J 23:342-5. 2004..We assessed available information, including the extent to which preexisting medical conditions may have put these children at higher than normal risk of death... - Infectious complications of biologic treatments of rheumatoid arthritisAparna K Mohan
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Rockville, Maryland 20852, USA
Curr Opin Rheumatol 15:179-84. 2003..The authors review the infectious complications of the use of these agents as reported in the medical literature from November 2001 through October 2002... - Cancer and other causes of mortality among radiologic technologists in the United StatesAparna K Mohan
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7244, USA
Int J Cancer 103:259-67. 2003.... - Cancer incidence in the US radiologic technologists health study, 1983-1998Alice J Sigurdson
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
Cancer 97:3080-9. 2003..The observed excesses of melanoma and thyroid cancers may reflect, at least in part, earlier detection among medical workers with easy access to health care... - Estimating historical radiation doses to a cohort of U.S. radiologic technologistsSteven L Simon
Division of Cancer Epidemiology and Genetics, National Cancer Institute NCI, National Institutes of Health, Bethesda, Maryland, USA
Radiat Res 166:174-92. 2006..The models and predictions presented here, while continuing to be modified and improved, represent one of the most comprehensive dose reconstructions undertaken to date for a large cohort of medical radiation workers... - Mortality from diseases of the circulatory system in radiologic technologists in the United StatesMichael Hauptmann
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Am J Epidemiol 157:239-48. 2003..007 and < 0.001, respectively). The data suggest increased mortality from diseases of the circulatory system with occupational radiation exposure before 1950 when radiation doses were likely high... - Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug AdministrationJennifer J Wood
Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA
J Bone Joint Surg Am 88:503-7. 2006..8%) had an adverse event that was reported to the Food and Drug Administration. CONCLUSIONS: The most common adverse events reported in association with the Carticel technique involved graft failure, delamination, and tissue hypertrophy... - Drug-induced systemic lupus erythematosus and TNF-alpha blockersAparna K Mohan
Lancet 360:646. 2002 - Estimating post-marketing exposure to pharmaceutical products using ex-factory distribution dataTamara Telfair
Johnson and Johnson Pharmaceutical Research and Development, Benefit-Risk Management Department, Epidemiology Division, Titusville, NJ 08560, USA
Pharmacoepidemiol Drug Saf 15:749-53. 2006..The present estimation approach is practical and relatively uncomplicated to implement. We believe it is a useful innovation...